Astec Lifesciences Profit & Loss Annual

Trade
BSE: 533138 | NSE: ASTEC | ISIN: INE563J01010 | Sector: Chemical Manufacturing
1,058.25 -2.40 (-0.23%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 458.18628.17676.57554.87
Total Revenue 458.18628.17676.57554.87
Costof Revenue Total 319.28458.62439.71376.79
Gross Profit 138.90169.54236.85178.08
Selling/ General/ Admin Expenses Total 61.7483.1373.1358.78
Depreciation/ Amortization 36.2533.6534.3625.66
Other Operating Expenses Total 83.078.158.746.81
Total Operating Expense 500.35585.04556.85468.95
Operating Income -42.1743.13119.7285.92
Interest Inc( Exp) Net- Non- Op Total -252.26-77.17-11.87-4.46
Other Net 5.640.062.583.62
Net Income Before Taxes -61.7534.95121.1389.07
Provisionfor Income Taxes -14.869.3531.2424.00
Net Income After Taxes -46.8925.5989.8865.07
Minority Interest -0.04-0.03-0.02-0.02
Net Income Before Extra Items -46.9325.5689.8665.05
Net Income -46.9325.5689.8665.05
Income Availableto Com Excl Extra Ord -46.9325.5689.8665.05
Income Availableto Com Incl Extra Ord -46.9325.5689.8665.05
Diluted Net Income -46.9325.5689.8665.05
Diluted Weighted Average Shares 1.961.961.961.96
Diluted EPS Excluding Extra Ord Items -23.9313.0445.8533.21
Diluted Normalized EPS -23.9313.2345.8433.21
Research Development -14.859.149.22
Gain( Loss)on Saleof Assets --5.240.14-0.17
DPS- Common Stock Primary Issue -1.501.501.50
Dilution Adjustment --0.00-
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts